Form 4: Exact Sciences Executive Jacob Orville Reports Stock and Restricted Stock Unit Transactions

EVP and GM of Screening at Exact Sciences, Jacob Orville, reports acquisition of restricted stock units and holdings in common stock and a 401(k) plan.

Summary

• On August 5, 2024, Jacob A. Orville, EVP and GM of Screening at Exact Sciences Corp, reported transactions involving the company's securities.
• Orville acquired 21,401 restricted stock units (RSUs) which convert to common stock.
• These RSUs vest in four equal annual installments starting August 5, 2025.
• Orville directly owns 14,440 shares of common stock and indirectly owns 1,117 shares through a 401(k) plan.
• In total, Orville holds 15,557 shares of common stock, in addition to 72,107 vested and unvested options and restricted stock units.

Sentiment

Score: 5

Explanation: Neutral sentiment as this is a standard SEC filing related to executive compensation. It doesn't inherently indicate positive or negative performance.

Positives

• The acquisition of restricted stock units by an executive could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The restricted stock units vest in four equal annual installments beginning on August 5, 2025, suggesting a long-term incentive for the executive.

Industry Context

Insider transactions are closely watched as they can provide insights into management's perspective on the company's valuation and future prospects. This Form 4 filing is a routine disclosure required by the SEC.

Stakeholder Impact

• Shareholders may be interested in this information as it provides insight into executive compensation and ownership.

Key Dates